The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...

DTC prescription drug models are reshaping the pharma industry by altering pricing dynamics and enhancing patient access, ...

Barclays 23rd Annual Global Technology Conference December 11, 2025 11:05 AM ESTCompany ParticipantsJudson Althoff - ...

This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...

Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

The UK's 14.5% drug rebate reduction may help to quell souring pharma sentiments, which stem from the nation's low spending on innovative drugs.

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active ...

Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.